Matthias W Beckmann

Author PubWeight™ 279.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
2 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005 5.70
3 Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009 5.05
4 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
5 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
6 Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010 4.51
7 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
8 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
9 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
10 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
11 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
12 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
13 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
14 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 2009 2.88
15 Hysterectomy-a comparison of approaches. Dtsch Arztebl Int 2010 2.77
16 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
17 A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012 2.45
18 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
19 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 2.09
20 Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES). Arch Gynecol Obstet 2013 2.06
21 Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 2008 1.99
22 Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009 1.90
23 Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011 1.84
24 Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer 2011 1.83
25 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
26 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
27 Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012 1.67
28 Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med (Berl) 2005 1.67
29 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
30 ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol 2013 1.61
31 Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod 2005 1.59
32 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009 1.58
33 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
34 Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013 1.56
35 Evaluation of high-sensitivity C-reactive protein in comparison with C-reactive protein as biochemical serum markers in women with endometriosis. Fertil Steril 2009 1.51
36 Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res 2010 1.51
37 Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Breast Cancer Res Treat 2007 1.49
38 On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography. Phys Med Biol 2013 1.47
39 Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril 2010 1.44
40 The extracorporeal perfusion of the swine uterus as an experimental model: The effect of tocolytic drugs. Eur J Obstet Gynecol Reprod Biol 2005 1.41
41 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
42 Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci (Lond) 2003 1.39
43 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
44 Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2011 1.33
45 Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 2010 1.29
46 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.29
47 CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 2012 1.29
48 Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 2013 1.28
49 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
50 Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 2012 1.26
51 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
52 The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012 1.23
53 Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. J Mol Med (Berl) 2006 1.22
54 Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007 1.22
55 The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 2008 1.21
56 Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011 1.17
57 Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010 1.17
58 Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 2009 1.16
59 Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients. Breast 2009 1.15
60 Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol 2010 1.14
61 Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 2006 1.14
62 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
63 The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations. Fertil Steril 2005 1.13
64 Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev 2008 1.12
65 Invasive Breast Cancer: Recognition of Molecular Subtypes. Breast Care (Basel) 2011 1.09
66 Characterizing mammographic images by using generic texture features. Breast Cancer Res 2012 1.07
67 Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 2007 1.06
68 Mammographic density as a risk factor for breast cancer in a German case-control study. Eur J Cancer Prev 2011 1.05
69 The Hohl instrument for optimizing total laparoscopic hysterectomy procedures. J Minim Invasive Gynecol 2005 1.03
70 An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res 2003 1.02
71 Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiol Biomarkers Prev 2012 1.02
72 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
73 Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis. Int J Fertil Womens Med 2007 0.99
74 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
75 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
76 Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial. Breast Cancer Res Treat 2010 0.98
77 Feasibility and safety of total laparoscopic hysterectomy (TLH) using the Hohl instrument in nonobese and obese women. J Obstet Gynaecol Res 2010 0.98
78 Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice. Fertil Steril 2006 0.98
79 High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia. J Med Genet 2011 0.98
80 Comparison of total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH) in women with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2009 0.97
81 The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer. Breast Care (Basel) 2010 0.97
82 Adhesion structures of amniotic membranes integrated into human corneas. Invest Ophthalmol Vis Sci 2006 0.97
83 The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center. Arch Gynecol Obstet 2011 0.96
84 Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol 2005 0.95
85 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012 0.95
86 Single-source tumor documentation - reusing oncology data for different purposes. Onkologie 2013 0.95
87 Female genital malformations and their associated abnormalities. Fertil Steril 2006 0.94
88 Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes. J Mol Med (Berl) 2010 0.93
89 Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. Fertil Steril 2009 0.93
90 Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care. BMC Cancer 2009 0.93
91 Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen. Int J Cancer 2008 0.92
92 Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer 2012 0.92
93 Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev 2013 0.92
94 Integration patterns of cryopreserved amniotic membranes into the human cornea. Ophthalmology 2006 0.92
95 Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 2012 0.91
96 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 2010 0.91
97 Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal Bioanal Chem 2010 0.91
98 Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology. Strahlenther Onkol 2011 0.91
99 Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 2006 0.91
100 Hormone replacement therapy and prognosis in ovarian cancer patients. Eur J Cancer Prev 2013 0.90
101 Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer 2014 0.90
102 IT infrastructure components to support clinical care and translational research projects in a comprehensive cancer center. Stud Health Technol Inform 2011 0.90
103 Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany. Dtsch Arztebl Int 2012 0.90
104 Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis. Breast Cancer Res Treat 2013 0.90
105 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
106 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet 2014 0.89
107 Offspring after embryo-preserving biopsy of the embryoblast with standard ICSI equipment in mouse blastocysts. In Vivo 2011 0.89
108 Malformations in a cohort of 284 women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH). Reprod Biol Endocrinol 2012 0.89
109 Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System. Breast Care (Basel) 2011 0.89
110 Thyroid hormone receptors and reproduction. J Reprod Immunol 2011 0.89
111 Endocrinological markers for assessment of hyperandrogenemia in hirsute women. Horm Res 2006 0.89
112 Financing of certified centers: a willingness-to-pay analysis. Arch Gynecol Obstet 2012 0.89
113 Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol 2013 0.89
114 The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs. Breast Cancer Res Treat 2006 0.88
115 Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. Eur J Endocrinol 2009 0.88
116 Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow. Tissue Eng Part A 2013 0.88
117 Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001. Biochem Pharmacol 2011 0.88
118 Improved safety of autologous breast reconstruction surgery by stabilisation of microsurgical vessel anastomoses using fibrin sealant in 349 free DIEP or fascia-muscle-sparing (fms)-TRAM flaps: a two-centre study. Breast 2008 0.87
119 Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets. Oncotarget 2012 0.87
120 Placental defence is considered sufficient to control lipid peroxidation in pregnancy. Med Hypotheses 2005 0.86
121 Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol 2013 0.86
122 Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice--no evidence of malignant cell contamination. Fertil Steril 2011 0.86
123 Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One 2013 0.86
124 Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis. J Cell Biochem 2012 0.86
125 Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 2007 0.86
126 Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study. Onkologie 2010 0.86
127 Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol 2007 0.86
128 Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome? Reprod Biomed Online 2008 0.85
129 Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys 2010 0.85
130 Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 2004 0.85
131 Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies. Breast Cancer Res Treat 2014 0.85
132 Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 2004 0.84
133 HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics. Breast Cancer Res Treat 2014 0.84
134 First live birth in germany after re-transplantation of cryopreserved ovarian tissue: original device for initiation of ice formation. Clin Lab 2012 0.84
135 Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome. Reproduction 2008 0.84
136 The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J Affect Disord 2011 0.84
137 Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians. Breast Cancer Res Treat 2012 0.84
138 Comparison of re-operation rates and complication rates after total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH). Eur J Obstet Gynecol Reprod Biol 2011 0.84
139 Comparison of different diagnostic procedures for the staging of malformations associated with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril 2011 0.84
140 A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer. Breast Cancer Res Treat 2012 0.84
141 Assessment of breast cancer tumour size using six different methods. Eur Radiol 2010 0.84
142 Preoperative pain and recurrence risk in patients with peritoneal endometriosis. Gynecol Endocrinol 2010 0.84
143 The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies. Strahlenther Onkol 2006 0.84
144 Breast volumetry using a three-dimensional surface assessment technique. Aesthetic Plast Surg 2011 0.83
145 Grating-based darkfield imaging of human breast tissue. Z Med Phys 2013 0.83
146 Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy. Acta Obstet Gynecol Scand 2010 0.83
147 Increased uterine arterial pressure and contractility of perfused swine uterus after treatment with serum from pre-eclamptic women and endothelin-1. Clin Sci (Lond) 2005 0.83
148 The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction 2007 0.83
149 Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011 0.83
150 Assessment of mammographic density before and after first full-term pregnancy. Eur J Cancer Prev 2010 0.83
151 Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. J Sex Med 2010 0.83
152 Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response. Eur Radiol 2011 0.83
153 Simple prediction of the survival of follicles in cryopreserved human ovarian tissue. J Reprod Dev 2006 0.82
154 Correlates of the desire for improved cosmetic results after breast-conserving therapy and mastectomy in breast cancer patients. Breast 2008 0.82
155 HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina. Gene 2013 0.82
156 Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Int J Gynecol Cancer 2014 0.82
157 Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10. Differentiation 2013 0.82
158 Tissue remodeling and nonendometrium-like menstrual cycling are hallmarks of peritoneal endometriosis lesions. Reprod Sci 2012 0.82
159 Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report. Arch Gynecol Obstet 2008 0.82
160 Maillard reaction products inhibit oxidation of human low-density lipoproteins in vitro. J Agric Food Chem 2003 0.82
161 Spontaneous antral follicle formation and metaphase II oocyte from a non-stimulated prepubertal ovarian tissue xenotransplant. Reprod Biol Endocrinol 2014 0.82
162 Intrauterine growth restriction (IUGR) is associated with increased leptin synthesis and binding capability in neonates. Clin Endocrinol (Oxf) 2011 0.82
163 CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2013 0.82
164 Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res 2014 0.82
165 Review. Fertility preservation for young female cancer patients. In Vivo 2009 0.81
166 Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis. BMC Cancer 2012 0.81
167 Financial viability of perinatal centers in the longer term, taking legislative requirements into account. An examination of the cost-revenue structure of a Level I perinatal center. In Vivo 2013 0.81
168 Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2012 0.81
169 Demographic and psychosocial factors associated with risk perception for breast cancer. Oncol Rep 2005 0.81
170 Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008. Arch Gynecol Obstet 2013 0.81
171 Pain perception and detailed visual pain mapping in breast cancer survivors. Breast Cancer Res Treat 2009 0.80
172 Concentrations of Nepsilon-carboxymethyllysine in human breast milk, infant formulas, and urine of infants. J Agric Food Chem 2006 0.80
173 Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system. Onkologie 2010 0.80
174 Cryopreservation of complex systems: slow freezing has not had its day yet. Rejuvenation Res 2007 0.80
175 Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 2016 0.80
176 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet 2011 0.80
177 A hybrid method towards automated nipple detection in 3D breast ultrasound images. Conf Proc IEEE Eng Med Biol Soc 2014 0.80
178 Uterine contractility in response to different prostaglandins: results from extracorporeally perfused non-pregnant swine uteri. Hum Reprod 2006 0.80
179 FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients. BMC Cancer 2014 0.80
180 Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates. Am J Obstet Gynecol 2007 0.80
181 Differences in muscarinic-receptor agonist-, oxytocin-, and prostaglandin-induced uterine contractions. Fertil Steril 2008 0.80
182 Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. J Psychiatr Res 2012 0.80
183 HIV-associated hypertrophic herpes simplex genitalis with concomitant early invasive squamous cell carcinoma mimicking advanced genital cancer: case report and literature review. Int J Gynecol Pathol 2012 0.80
184 Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol 2007 0.80
185 Association of molecular subtypes with breast cancer risk factors: a case-only analysis. Eur J Cancer Prev 2015 0.79
186 Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. J Clin Endocrinol Metab 2007 0.79
187 Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Res 2015 0.79
188 Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL. Biochem Biophys Res Commun 2004 0.79
189 Influence of diet on exposure to acrylamide--reflections on the validity of a questionnaire. Ann Nutr Metab 2005 0.79
190 Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy. Anticancer Res 2007 0.79
191 Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata). Pathology 2013 0.79
192 Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 2012 0.79
193 Dexamethasone stimulates the expression of leptin and 11β-HSD2 in primary human placental trophoblastic cells. Eur J Obstet Gynecol Reprod Biol 2011 0.79
194 Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients. Arch Gynecol Obstet 2012 0.79
195 Designing and implementing a biobanking IT framework for multiple research scenarios. Stud Health Technol Inform 2012 0.78
196 Comparison of two freezing protocols in an open freezing system for cryopreservation of rat ovarian tissue. J Obstet Gynaecol Res 2006 0.78
197 Treatment of heterotopic cervical pregnancies. Fertil Steril 2010 0.78
198 Factors influencing breast changes after pregnancy. Eur J Cancer Prev 2013 0.78
199 Perfused non-pregnant swine uteri: a model for evaluating transport mechanisms to the side bearing the dominant follicle in humans. J Reprod Dev 2006 0.78
200 Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. Pharmacogenomics 2010 0.78
201 Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors. Breast Cancer Res Treat 2013 0.78
202 Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis. Gynecol Endocrinol 2009 0.77
203 Hormonal and histologic findings in human cryopreserved ovarian autografts. Fertil Steril 2008 0.77
204 The extracorporeal perfusion of the female pig detrusor as an experimental model for the study of bladder contractility. Neurourol Urodyn 2007 0.77
205 Course of ovarian hyperstimulation syndrome in 19 intact twin pregnancies after assisted reproduction techniques, with a case report of severe thromboembolism. Twin Res Hum Genet 2006 0.77
206 Accuracy of cervical cancer staging needs improvement. Am J Obstet Gynecol 2005 0.77
207 Workflows in cancer treatment and their influence upon clinical documentation. Stud Health Technol Inform 2013 0.77
208 Development of sex cord stromal tumors after heterotopic transplantation of cryopreserved ovarian tissue in rats. Anticancer Res 2005 0.77
209 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
210 Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. J Clin Endocrinol Metab 2008 0.77
211 Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol 2015 0.77
212 Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study. Fertil Steril 2008 0.77
213 Correlates of mammographic density in B-mode ultrasound and real time elastography. Eur J Cancer Prev 2012 0.77
214 Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Reprod Biomed Online 2009 0.77
215 Comprehensive visualization of paresthesia in breast cancer survivors. Arch Gynecol Obstet 2014 0.76
216 Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk. Am J Obstet Gynecol 2008 0.76
217 Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures. Eur J Obstet Gynecol Reprod Biol 2013 0.76
218 An EMR based cancer diary - utilisation and initial usability evaluation of a new cancer data visualization tool. Stud Health Technol Inform 2012 0.76
219 Simultaneous amniotic membrane patch in high-risk keratoplasty. Cornea 2011 0.76
220 Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment. Int J Fertil Womens Med 2008 0.76
221 The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome. Fertil Steril 2010 0.76
222 Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery. Anticancer Res 2006 0.76
223 Influence of maternal smoking during pregnancy on oxidant status in amniotic fluid. In Vivo 2012 0.76
224 Delivery mode and the course of pre- and postpartum depression. Arch Gynecol Obstet 2012 0.76
225 The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. Breast Cancer Res Treat 2011 0.76
226 Visual pain mapping in endometriosis. Arch Gynecol Obstet 2012 0.76
227 Chelidonium majus and its effects on uterine contractility in a perfusion model. Eur J Obstet Gynecol Reprod Biol 2013 0.76
228 High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol 2005 0.76
229 Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril 2009 0.76
230 Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertil Steril 2012 0.76
231 SPECT/Spiral-CT hybrid imaging in unclear foci of increased bone metabolism: a case report. Rontgenpraxis 2005 0.75
232 Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy. Breast Cancer Res 2012 0.75
233 Does lymphatic involvement impact survival of early stage cervical cancer patients? Onkologie 2009 0.75
234 Hormones and genetics caught in the crossfire of preventive medicine. Lancet Oncol 2007 0.75
235 The perfused swine uterus model: long-term perfusion. Reprod Biol Endocrinol 2012 0.75
236 Ductal carcinoma in situ -- do we really need a new nomenclature? Onkologie 2009 0.75
237 Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer. Expert Rev Anticancer Ther 2010 0.75
238 Pregnancy outcome after maternal intoxication with phenprocoumon. Br J Clin Pharmacol 2011 0.75
239 Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2015 0.75
240 Subjective assessment of ovarian masses using pattern recognition: the impact of experience on diagnostic performance and interobserver variability. Arch Gynecol Obstet 2012 0.75
241 Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy. Arch Gynecol Obstet 2014 0.75
242 Is laparoscopic extirpation of the cervical stump after laparoscopic supracervical hysterectomy justified in women with incidentally found atypical endometrial hyperplasia? J Laparoendosc Adv Surg Tech A 2011 0.75
243 Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 2017 0.75
244 Computer-assisted diagnosis (CAD) in colposcopy: evaluation of a pilot study. Anticancer Res 2012 0.75
245 Health utilities in gynecological oncology and mastology in Germany. Anticancer Res 2014 0.75
246 State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer. Oncol Res Treat 2016 0.75
247 Expression of the human endogenous retroviruse-W envelope gene syncytin in endometriosis lesions. Gynecol Endocrinol 2009 0.75
248 Erratum: Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci Rep 2016 0.75
249 Cullin 7 and Fbxw 8 expression in trophoblastic cells is regulated via oxygen tension: implications for intrauterine growth restriction? J Matern Fetal Neonatal Med 2012 0.75
250 Fulvestrant: a further treatment option for patients with metastatic uterine cancer? Onkologie 2006 0.75
251 Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment. Curr Opin Obstet Gynecol 2017 0.75
252 Severe ovarian hyperstimulation syndrome in a twin pregnancy after intracytoplasmic sperm injection. J Obstet Gynaecol Res 2007 0.75
253 Role of insulin in the progression of ovarian sex cord stromal tumors in rats. J Cancer Res Clin Oncol 2005 0.75
254 Psychological Predictors of Acute Postoperative Pain After Hysterectomy for Benign Causes. Clin J Pain 2017 0.75
255 Porcine uterus cryopreservation: an analysis of contractile function using different uterotonics. Cryobiology 2012 0.75
256 Increased accuracy of fetal weight estimation with a gender-specific weight formula. Fetal Diagn Ther 2008 0.75
257 Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment. Anticancer Res 2010 0.75
258 Corrigendum: Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci Rep 2016 0.75
259 Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE study. Eur J Cancer Prev 2014 0.75
260 Virilizing Hilus Cell Tumor of the Ovary Associated With Efferent Ductules-like Metaplasia Within Paratubal Mesonephric Remnants. Int J Gynecol Pathol 2016 0.75
261 Uterus cryopreservation in the sheep: one step closer to uterus transplantation. In Vivo 2010 0.75
262 The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia. In Vivo 2006 0.75
263 Computer-assisted diagnosis in colposcopy: results of a preliminary experiment? Acta Cytol 2012 0.75